(Q43824306)

English

The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study

scientific article published in September 2001

Statements

The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study (English)
1 September 2001
1444-1450

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit